Innovation Partners for Aerobiology & Biomedical Research

Research into indoor health announced during networking event with Irish PM.

President Obama had his traditional annual meeting with Irish Prime Minister, Enda Kenny, during a St. Patrick's Day visit in Washington DC. A large number of Irish-American trade related events took place around the visit to highlight the recovery of the Irish economy, with particular focus on the growth of the med-tech and biomedical research sectors with American companies in Ireland.

airmid healthgroup (AHG) was pleased to be among those attending the events. At a business networking lunch Dr John McKeon, Co-Founder of airmid healthgroup was delighted to introduce Joseph Gargiulo representing Stanley Steemer, to the Prime Minister and announce further research in the area of indoor aerobiology and indoor health. A recent airmid study involving Stanley Steemer was presented at the 2013 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI). The study found the Stanley Steemer deep cleaning process was proven to remove up to 97 percent of surface allergens. The study evaluated air and surface samples taken before and after hot water extraction in 20 U.S. homes. Additional findings revealed successful removal of 67 percent of airborne cat allergens as well. “This scientifically confirms what we’ve heard anecdotally from our customers with allergies and asthma for years,” said Justin Bates, president of Stanley Steemer, “and we are excited about moving into phase two of our research.”

DUBLIN, IRELAND and WASHINGTON, DC and MOUNTAIN VIEW, CA and SEATTLE, WA, Mar 18 (Marketwire)

This week, at events in cities from coast-to-coast, Irish Government officials, including Prime Minister (An Taoiseach) Enda Kenny, will reinforce and promote Ireland's ties with its largest trading partner, the U.S. The ties continue to strengthen. As their businesses expand in the U.S., Ireland-based companies are broadening their footprint and boosting headcount. Today, Ireland is the 14th largest investor in the U.S., with 300 Irish companies across all 50 states collectively employing more than 82,000 Americans. The investment flows both ways. U.S. companies continued to select Ireland as their European hub last year, while many existing corporate tenants expanded their Irish operations. In total, more than 600 U.S. companies have a presence on the island.

Washington, D.C., Silicon Valley and Seattle will anchor the Prime Minister's agenda. Coordinating several events on the itinerary is Enterprise Ireland, the government agency responsible for the development and internationalization of Irish enterprises.

It’s the time of year again for the American Academy of Asthma Allergy and Immunology (AAAAI) Annual Meeting in San Antonio Texas (February 22-26). The meeting will be attended by more than 7,700 allergist/immunologists, related physicians, and industry representatives.

Following on from our presentation at the meeting last year, the airmid research team will again be travelling to the USA to present biomedical research data related to indoor air quality and health. The exciting research which is sure to stimulate some interesting debate is embargoed until after it has been presented. We will however be making some of the details public after the event. Click here for details.

The analysis of the samples again utilized the airmid allergen analysis facility, the only one of its type in the world with ISO 17025 accreditation. As a world leading biomedical research organisation, airmid help clients across a number of sectors improve, add value and differentiate their customer offerings through a focus on biomedical data, health impact claims and air quality.

It’s that time of year again and Orlando Florida hosts the American Academy of Asthma Allergy and Immunology (AAAAI) Annual Meeting this year from March 2-6. The AAAAI Annual Meeting draws the allergy and immunology specialty's academic and clinical leaders to showcase new research and discuss other developments in allergy, asthma and immunologic diseases. The meeting is attended by more than 7,700 allergist/immunologists, related physicians, allied health professionals and industry representatives.